Orlando Man Found Guilty of Conspiring to Distribute Fentanyl that Resulted in Death
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Orlando Man Found Guilty of Conspiring to Distribute Fentanyl that Resulted in Death

Orlando Man Found Guilty of Conspiring to Distribute Fentanyl that Resulted in Death

July 02, 2024
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Miami.FD.PIO@dea.gov
Phone Number: (571) 362-3364 - Option 5

ORLANDO, Fla. – United States Attorney Roger B. Handberg announced that a federal jury has found Joel David Fonseca Flores (42, Orlando) guilty of conspiring to distribute fentanyl that resulted in death. He faces a minimum mandatory sentence of 20 years, up to life, in federal prison. His sentencing hearing is scheduled for October 7, 2024.

Fonseca Flores and his co-conspirator, Misty Lynn Parady, were charged by superseding indictment on August 16, 2023. Count one of the superseding indictment charged Fonseca Flores and Parady with conspiracy to distribute and possess with intent to distribute a mixture and substance containing a detectable amount of fentanyl, resulting in N.K.’s death, as described above. Count two charged Fonseca Flores and Parady with aiding and abetting in the possession with intent to distribute a mixture and substance containing a detectable amount of fentanyl and cocaine. Count three charged Flores with knowingly possessing a firearm in furtherance of a drug trafficking crime. Fonseca Flores pleaded guilty to counts two and three of the superseding indictment on June 3, 2024.

According to evidence presented at trial, Fonseca Flores and Parady sold fake “M30” pills laced with fentanyl to the victim, N.K. Between April 2020 and April 2022, Fonseca Flores and Parady sold N.K. what she, at first, believed to be oxycodone. After some time, N.K. realized that the pills she was buying from them contained fentanyl.

Specifically, on October 31, 2021, N.K. warned Parady by text message that N.K. had tested positive for fentanyl. Parady relayed that information to Fonseca Flores. Then, again on March 31, 2022, within days of purchasing “M30” pills from Fonseca Flores, N.K. sent a text message to Parady containing an image of her drug test, showing that N.K. had tested negative for oxycodone and positive for fentanyl.

Despite these and other warnings, Fonseca Flores and Parady continued to supply N.K. with the counterfeit fentanyl pills, and N.K. ultimately died from a fentanyl overdose on April 4, 2022.

Parady pleaded guilty to a superseding information on May 24, 2024, and faces a maximum penalty of 20 years in federal prison. Her sentencing is scheduled for August 26, 2024.

Pursuant to the superseding indictment, Fonseca Flores must also forfeit all firearms and ammunition involved in or used in the charged offenses, including, but not limited to a Ruger 9mm pistol and associated ammunition.

This case was investigated by the Drug Enforcement Administration and the Orlando Police Department Overdose Unit. It is being prosecuted by the United States Attorney’s Office for the Middle District of Florida.  

This case is part of Project Safe Neighborhoods (PSN), a program bringing together all levels of law enforcement and the communities they serve to reduce violent crime and gun violence, and to make our neighborhoods safer for everyone. On May 26, 2021, the Department launched a violent crime reduction strategy strengthening PSN based on these core principles: fostering trust and legitimacy in our communities, supporting community-based organizations that help prevent violence from occurring in the first place, setting focused and strategic enforcement priorities, and measuring the results.

If you are aware of controlled substance violations in your community, please submit your anonymous tip through the DEA online Tip Line at Submit a Tip | DEA.gov.  Concerns about prescription drug abuse or diversion can be reported to the DEA through this link: RX Abuse Online Reporting (usdoj.gov).

The DEA encourages parents, teachers, care givers, guardians, and children to educate themselves about the dangers of drugs by visiting DEA’s interactive websites at www.JustThinkTwice.com , www.GetSmartAboutDrugs.com, www.CampusDrugPrevention.gov, and www.dea.gov.

Follow DEA Miami via Twitter at @DEAMIAMIDIV.

Download Press Release
###
Fentanyl
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Deanne L. Reuter Special Agent in Charge - Miami
@deamiamidiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster